![logo](/logos/CSBR.webp)
Champions Oncology, Inc.
NASDAQ:CSBR
4.25 (USD) • At close September 5, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Champions Oncology, Inc. |
Symbool | CSBR |
Munteenheid | USD |
Prijs | 4.25 |
Beurswaarde | 57,773,650 |
Dividendpercentage | 0% |
52-weken bereik | 3.97 - 7.13 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Ronnie Morris M.D. |
Website | https://www.championsoncology.com |
An error occurred while fetching data.
Over Champions Oncology, Inc.
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)